Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2146 to 2160 of 9009 results

  1. Healthy.io test for home testing of urine albumin to creatinine ratio

    Topic prioritisation

  2. Cytokine adsorption technologies for treating respiratory failure in people with COVID-19

    Topic prioritisation

  3. Liposomal bupivacaine for treating postoperative pain [ID3799]

    Topic prioritisation

  4. Imbio CT lung texture analysis for identifying interstitial lung disease (MT618) (MIB272)

    Topic prioritisation

  5. Lenacapavir for treating multidrug resistant HIV-1 [ID6196]

    Topic prioritisation

  6. DV7103 for treating cystinuria in people 6 months and over [TSID10438]

    Topic prioritisation

  7. Riluzole oral film for treating amyotrophic lateral sclerosis [TSID11779]

    Topic prioritisation

  8. Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TSID10723]

    Topic prioritisation

  9. Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085]

    Topic prioritisation

  10. Glucarpidase for reducing toxic plasma methotrexate levels in people aged 28 days and over [TSID10761]

    Topic prioritisation

  11. Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998]

    Topic prioritisation

  12. Avtozma (tocilizumab biosimilar) for treating moderate to severe rheumatoid arthritis in people aged 18 to 75 [TSID11848]

    Topic prioritisation

  13. Dapsone for treating COVID-19 in people 40 years and over with high-risk comorbidity and people 70 years and over [TSID11892]

    Topic prioritisation

  14. Camizestrant for treating oestrogen receptor-positive HER2-negative early breast cancer at risk of recurrence after 2 to 5 years of adjuvant endocrine treatment [TSID12348]

    Awaiting development Reference number: GID-TA11987 Expected publication date: TBC